Moreover, the re-expression of linc-PINT and HMOX1 is observed upon treatment of ALL with epigenetic drugs, and therefore, it may be one of the molecular mechanisms induced by these drugs to cause anti-tumor effects in this disease. This evidence concerns the gene HMOX1 and acute lymphoblastic leukemia.